Common Contracts
4 similar Registration Rights Agreement contracts by Oragenics Inc, Fibrocell Science, Inc., Synthetic Biologics, Inc.
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 9th, 2017 • Oragenics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 8th day of November, 2017 by and among Oragenics, Inc., a Florida corporation (the “Company”), and each of the several holders of Registrable Securities (as defined below) signatory hereto (each such holder, a “Holder” and, collectively, the “Holders”). Capitalized terms used herein have the respective meanings ascribed thereto in that certain Securities Purchase Agreement dated November 8, 2017 by and among the Company and the other parties signatory thereto (the “Purchase Agreement”) unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 12th, 2017 • Synthetic Biologics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this September 11, 2017 by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), and MSD Credit Opportunity Master Fund, L.P., a Delaware limited partnership (together with each subsequent holder of Registrable Shares, collectively, the “Holders” and, each individually, a “Holder”). Capitalized terms used herein have the respective meanings ascribed thereto in that certain Share Purchase Agreement dated as of the date hereof by and among the Company and the other parties signatory thereto (the “Purchase Agreement”) unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 11th, 2017 • Oragenics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 10th day of May, 2017 by and among Oragenics, Inc., a Florida corporation (the “Company”), and each of the several holders of Registrable Securities (as defined below) signatory hereto (each such holder, a “Holder” and, collectively, the “Holders”). Capitalized terms used herein have the respective meanings ascribed thereto in that certain Securities Purchase Agreement dated May 10, 2017 by and among the Company and the other parties signatory thereto (the “Purchase Agreement”) unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 8th, 2016 • Fibrocell Science, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 7th day of September, 2016 by and among Fibrocell Science, Inc., a Delaware corporation (the “Company”), and each of the several holders of Registrable Shares (as defined below) signatory hereto (each such holder, a “Holder” and, collectively, the “Holders”).
